#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Central nervous system lymphoma Immune-mediated enterocolitis Hypotransferrinaemia Oropharyngeal cancer recurrent Allogenic stem cell transplantation Cystic fibrosis gastrointestinal disease Small for dates baby Myeloproliferative neoplasm Leiomyosarcoma Primary myelofibrosis Bladder cancer Breast angiosarcoma Fms-like tyrosine kinase 3 positive Osteomyelitis Ependymoma More trials…

    Learn about Rare Diseases

    MELAS syndrome – Diagnostics Netherton’s syndrome – Diagnostics Haemophilia A without inhibitors – Diagnostics Sjogren’s syndrome – Diagnostics Alveolar rhabdomyosarcoma – Diagnostics Krabbe’s disease – Basic Information Usher’s syndrome Primary biliary cholangitis – Life with Disease Progressive supranuclear palsy – Diagnostics Leukoencephalopathy – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Somapacitan Aluminium 64CU-PSMA I&T Omp66 Folinic Acid Eprosartan Mesilate Zanamivir L-ALANINE Remifentanil Hydrochloride SONLICROMANOL HYDROCHLORIDE Anidulafungin Eight Treg Inclisiran Sodium BENZYLPENICILLIN PROCAINE Dog Epithelia Hmb-001 Human Fibrinogen Labetalol Hydrochloride Cdr132L AUR200 More therapies…

    Learn about Your Condition

    Type IIa hyperlipidaemia Colorectal cancer stage II Short stature Mantle cell lymphoma recurrent Wolfram syndrome Drug dependence Cardiac failure Ligament sprain Adenocarcinoma pancreas Diabetic foot infection Mesothelioma malignant Endocrine disorder Hyponatraemia Myotonia Myeloproliferative neoplasm More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of vaginal pentoxifylline gel PKB171 compared to placebo in couples with mild male infertility due to low sperm count or poor sperm movement

    Recruiting

    4 1
    Investigated Diseases:
    • Infertility male
    Investigated Drugs:
    • Pentoxifylline
    Spain

  • Study of pembrolizumab with drug combination for first-line treatment in patients with advanced-stage classic Hodgkin lymphoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hodgkin’s disease
    Investigated Drugs:
    • Brentuximab Vedotin
    • Dacarbazine Citrate
    • Cyclophosphamide
    Germany

  • Comparison of REGN7508 versus apixaban and enoxaparin to prevent blood clots in adults after knee replacement surgery

    Recruiting

    3 1 1
    Investigated Diseases:
    • Embolism
    Investigated Drugs:
    • Regn7508
    • Sodium Chloride
    • Apixaban
    Bulgaria Hungary Latvia Lithuania Poland Romania

  • Study of AZD6793 tablets to reduce flare-ups in adults with moderate to very severe chronic obstructive pulmonary disease (COPD)

    Recruiting

    2 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Bulgaria Denmark Germany Greece Hungary Italy +2

  • Study of fampridine treatment for patients with spinocerebellar ataxia SCA27B caused by FGF14 gene mutation

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hereditary ataxia
    Investigated Drugs:
    • Fampridine
    France

  • Study of AlloNK and rituximab with cyclophosphamide and fludarabine in adults with relapsing rheumatoid arthritis, inflammatory myopathies, systemic sclerosis, or Sjögren’s disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    • Systemic scleroderma
    • Sjogren’s syndrome
    Investigated Drugs:
    • ALLOGENEIC UMBILICAL CORD BLOOD-DERIVED NATURAL KILLER CELLS, EX VIVO EXPANDED
    • Cyclophosphamide
    • Fludarabine Phosphate
    Bulgaria France Germany Italy Poland Portugal +2
Previous Page
1 … 135 136 137 138 139 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!